Login / Signup

Asthma Control in Patients with Severe Eosinophilic Asthma Treated with Reslizumab: Spanish Real-Life Data.

Luis A Perez-de-LlanoBorja García CosioIgnacio Lobato AstiárragaGregorio Soto CamposMiguel Ángel Tejedor AlonsoNuria Marina MalandaAlicia Padilla GaloIsabel Urrutia LandaFrancisco J Michel de la RosaIsmael García-Moguelnull null
Published in: Journal of asthma and allergy (2022)
Reslizumab is an effective therapy for SEUA with adequate safety profile in real-life conditions.
Keyphrases
  • chronic obstructive pulmonary disease
  • lung function
  • allergic rhinitis
  • electronic health record
  • big data
  • cystic fibrosis
  • air pollution
  • newly diagnosed
  • drug induced
  • deep learning
  • data analysis